vimarsana.com

Chromium Single Cell Gene Expression Flex News Today : Breaking News, Live Updates & Top Stories | Vimarsana

10x Genomics, Inc Share Price Target $58 50 , now 21 7% Upside Potential

10x Genomics, Inc. Share Price Target '$58.50', now 21.7% Upside Potential

Genomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

10x Genomics, Inc - Consensus buy rating and 21 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 21.0% Upside Potential

Paylocity holding corporationGenomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

Proteintech Genomics Launches First Commercially Available Solution for the Detection of Intracellular Proteins for Single-Cell RNAseq Experiments

SAN DIEGO (BUSINESS WIRE) Nov 6, 2023

San diegoUnited statesPeter smibertGenomics incProteintech groupProteintech group incHuman fixed cell immune profiling antibodySingle cell gene expression flexGenomic multiproBusiness wireProteintech genomicsKit nazorGenomic multipro immune profiling cocktailChromium single cell gene expression flexGroup incNational business

Proteintech Genomics launches new MultiPro Immune Profiling Cocktail

BioPharma

Peter smibertProteintech group incGenomics incProteintech groupFixed cell immune profiling antibodySingle cell gene expression flexProteintech genomicsKit nazorGenomic multipro immune profiling cocktailChromium single cell gene expression flex

10x Genomics Reports Third Quarter 2023 Financial Results

/PRNewswire/ 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended.

United statesHong kongSerge saxonovGenomics incXenium panel designerSecurities exchangeBeckman coulter life sciencesExchange commissionChromium single cell gene expression flexConference callPrivate securities litigation reform actSecurities actSecurities exchange actFinancial conditionConsolidated statementsMiddle east

vimarsana © 2020. All Rights Reserved.